ARCHIVES

Final stats On FY92 Budget; Success Rate Was 35 Percent

This article is from The Cancer Letter archive.

Vol. 18 No. 47 | December 4, 1992

Download PDF Visit The Full Archive

Related Articles

Non-Invasive Test May Detect Lung Cancer In Early Stages

September 26, 2003

Denosumab Demonstrates Superiority Over Zometa For Bone Metastases

August 28, 2009

FDA Approves Rituxan For NHL With CHOP Therapy

February 24, 2006

Gynecologic Oncology Group To Conduct Phase III Trial of Xyotax For Ovarian Cancer

April 30, 2004

ASCO Must Be An “Independent Voice” For Cancer Patients and Physicians, New EVP Allen Lichter says.

July 28, 2006

ORI Withdraws Requirement For Research Ethics Courses.

February 23, 2001